Your browser doesn't support javascript.
loading
Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US.
McGrath, Leah J; Scott, Amie M; Surinach, Andy; Chambers, Richard; Benigno, Michael; Malhotra, Deepa.
Affiliation
  • McGrath LJ; Real World Evidence Center of Excellence, Pfizer Inc, New York, New York.
  • Scott AM; Real World Evidence Center of Excellence, Pfizer Inc, New York, New York.
  • Surinach A; Genesis Research, Hoboken, New Jersey.
  • Chambers R; Global Product Development Statistics, Pfizer Inc, Collegeville, Pennsylvania.
  • Benigno M; Real World Evidence Center of Excellence, Pfizer Inc, New York, New York.
  • Malhotra D; Real World Evidence Center of Excellence, Pfizer Inc, New York, New York.
JAMA Netw Open ; 5(10): e2235089, 2022 10 03.
Article in En | MEDLINE | ID: mdl-36201207
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Aged / Child / Female / Humans / Middle aged Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Aged / Child / Female / Humans / Middle aged Language: En Year: 2022 Type: Article